StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Acro Biomedical

Acro Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Acro Biomedical figures

See a number that looks wrong?